SynTheAll Pharmaceutical Co. Ltd (“STA”), a subsidiary of WuXi AppTec, was awarded as “A Leading Enterprise of API Exports in 2014” and “Gold Exhibitor in API Manufacture and Trade” at CPhI China 2015 on June 23, 2015. Dr. Minzhang Chen, CEO of STA, was also named as “Most Influential People in API Exports” with the highest number of votes.
Established in 2003, STA is a global leading pharmaceutical contract development and manufacturing organization (CDMO). STA provides process chemistry services and manufactures small-molecule advanced intermediates and APIs for customer use in preclinical and clinical trials and for marketed commercial drugs. Its operations are located in the Waigaoqiao Free Trade Zone and Jinshan, both in Shanghai, and in Changzhou, Jiangsu Province. STA maintains a strong growth momentum since its inception and continuous to invest heavily to enhance its capability and capacity. STA is in the process of building new facilities in Changzhou to quadruple its production capacity. In recent years STA also established advanced continuous processing and biocatalysis technology platforms through in-depth collaboration with partners and customers.